Evidence map›Paper›PMID 23392246›Full record

ArticleRNA biology2013

HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.

Sebastian Eilebrecht, Emmanuelle Wilhelm, Bernd-Joachim Benecke, Brendan Bell, Arndt G Benecke

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Microglial Cells: The Main HIV-1 Reservoir in the Brain.Frontiers in cellular and infection microbiology · 2019
    Review
  7. Structural basis for recognition of human 7SK long noncoding RNA by the La-related protein Larp7.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The new (dis)order in RNA regulation.Cell communication and signaling : CCS · 2016
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. CTIP2 is a negative regulator of P-TEFb.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 5 countries.

Sebastian EilebrechtInstitut des Hautes Études Scientifiques - Centre National de la Recherche Scientifique; Bures sur Yvette; France & Vaccine Research Institute; Institut Mondor de Recherche Biomédicale; Créteil, France.
Emmanuelle Wilhelm
Bernd-Joachim Benecke
Brendan Bell
Arndt G Benecke
Université de Sherbrooke · CAFaculty (United Kingdom) · GBInstitut des Hautes Études Scientifiques · FRInstitut Mondor de Recherche Biomédicale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transactivating response element (TAR) of human immunodeficiency virus 1 (HIV-1) is essential for promoter transactivation by the viral transactivator of transcription (Tat). The Tat-TAR interaction thereby recruits active positive transcription elongation factor b (P-TEFb) from its inactive, 7SK/HEXIM1-bound form, leading to efficient viral transcription. Here, we show that the 7SK RNA-associating chromatin regulator HMGA1 can specifically bind to the HIV-1 TAR element and that 7SK RNA can thereby compete with TAR. The HMGA1-binding interface of TAR is located within the binding site for Tat and other cellular activators, and we further provide evidence for competition between HMGA1 and Tat for TAR-binding. HMGA1 negatively influences the expression of a HIV-1 promoter-driven reporter in a TAR-dependent manner, both in the presence and in the absence of Tat. The overexpression of the HMGA1-binding substructure of 7SK RNA results in a TAR-dependent gain of HIV-1 promoter activity similar to the effect of the shRNA-mediated knockdown of HMGA1. Our results support a model in which the HMGA1/TAR interaction prevents the binding of transcription-activating cellular co-factors and Tat, subsequently leading to reduced HIV-1 transcription.

Indexed as

HIV Long Terminal RepeatBinding SitesGene Expression Regulation, ViralGene Knockdown TechniquesHEK293 CellsHeLa CellsHIV-1HIV InfectionsHMGA1a ProteinHumansModels, GeneticNucleic Acid ConformationPositive Transcriptional Elongation Factor BPromoter Regions, GeneticRNA, Viraltat Gene Products, Human Immunodeficiency VirusHMGA1a ProteinPositive Transcriptional Elongation Factor BRNA, Viraltat Gene Products, Human Immunodeficiency Virus7SK snRNAelongationHIV-1HMGA1P-TEFbTARTattranscription

Identifiers

PMID23392246
PMCPMC3672287
OpenAlexW2089316366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.